These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 4681201)
1. The good, bad and potential role of the American pharmaceutical industry in the problem of drug abuse. Kline NS Int Pharmacopsychiatry; 1972; 7(1-4):162-7. PubMed ID: 4681201 [No Abstract] [Full Text] [Related]
2. Pharmaceutical manufacturers likely to be challenged by regulatory agencies over assertions of deceptive advertising. Fine A Exec Solut Healthc Manag; 1999 Jun; 2(6):2-3. PubMed ID: 10538255 [No Abstract] [Full Text] [Related]
3. Drugs and public policy. We need an alternative, not an escalation. Deschin CS Am J Orthopsychiatry; 1973 Jul; 43(4):519-23. PubMed ID: 4716667 [No Abstract] [Full Text] [Related]
4. PHYSICIAN RESPONSIBILITY FOR DRUG PRESCRIPTION. MILLS DH JAMA; 1965 May; 192():460-3. PubMed ID: 14284846 [No Abstract] [Full Text] [Related]
5. Regulating pharmaceutical advertising: what will work? Shapiro MF CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416 [TBL] [Abstract][Full Text] [Related]
6. PLANNING IN THE FOOD AND DRUG ADMINISTRATION FOR REGULATION OF PRESCRIPTION DRUG ADVERTISING. SADUSK JF Curr Ther Res Clin Exp; 1965 May; 7():332-6. PubMed ID: 14286216 [No Abstract] [Full Text] [Related]
7. To ban or not to ban--that is the question: the constitutionality of a moratorium on consumer drug advertising. Schwartz MI Food Drug Law J; 2008; 63(1):1-33. PubMed ID: 18561453 [No Abstract] [Full Text] [Related]
8. Drug manufacturers' liability for injuries due to drug abuse. Davis WA Leg Med Annu; 1974; 0(0):425-43. PubMed ID: 4461874 [No Abstract] [Full Text] [Related]
9. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health. Javitt GH; Stanley E; Hudson K Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034 [No Abstract] [Full Text] [Related]
10. Addressing the problem of misleading advertising. Kessler DA Ann Intern Med; 1992 Jun; 116(11):950-1. PubMed ID: 1580454 [No Abstract] [Full Text] [Related]
11. The role of government in implementing good nutritional practice. Wodicka VO Bull N Y Acad Med; 1971 Jun; 47(6):641-3. PubMed ID: 5280852 [No Abstract] [Full Text] [Related]
12. Senate hearings on program sponsorship: a bitter pill for the pharmaceutical industry? Waixel C Biomed Commun; 1976 Sep; 4(5):6-7. PubMed ID: 1027498 [No Abstract] [Full Text] [Related]
13. Direct-to-consumer advertising--education or emotion promotion? Wolfe SM N Engl J Med; 2002 Feb; 346(7):524-6. PubMed ID: 11844857 [No Abstract] [Full Text] [Related]
14. Prescription drug advertising--should states regulate what is false and misleading? Shaeffer J Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454 [No Abstract] [Full Text] [Related]
15. Direct-to-consumer advertising--strengthening our health care system. Holmer AF N Engl J Med; 2002 Feb; 346(7):526-8. PubMed ID: 11844858 [No Abstract] [Full Text] [Related]
16. Supreme Court okays prescription drug advertising; FTC to investigate possible AMA restraint of trade. Employee Benefit Plan Rev; 1976 Jul; 31(1):62-3. PubMed ID: 1037563 [No Abstract] [Full Text] [Related]
17. The FDA Bad Ad Program: implications for NPs. Fass JA Nurse Pract; 2011 Apr; 36(4):10-1. PubMed ID: 21422974 [No Abstract] [Full Text] [Related]
18. The role of direct-to-consumer pharmaceutical advertising in patient consumerism. Wang B; Kesselheim AS Virtual Mentor; 2013 Nov; 15(11):960-5. PubMed ID: 24257088 [No Abstract] [Full Text] [Related]